Indica Labs has announced an update to their Breast IHC AI suite, which now includes functionality for the detection of low and ultralow HER2 expression in breast cancer. Breast IHC AI is a suite of algorithms for performing WSI scoring of...

Albuquerque, NM, April 30, 2025 – Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an update to their Breast IHC AI suite, an image analysis tool used for the quantification of HER2, ER, PR, and...

Results published in JCO Precision Oncology; pathologists supported by Ibex Breast HER2 show improvement in HER2 scoring accuracy and consistency BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in...

South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...

Lunit: Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvironment is linked to treatment response of Pertuzumab+Trastuzumab in colorectal cancer [SEOUL, South Korea, August 1, 2023] Lunit...

Paige: Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low...